

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.67241045 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.64997115 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.64997115 |
| 4 | negative T cell selection (GO:0043383) | 5.57054666 |
| 5 | negative thymic T cell selection (GO:0045060) | 5.45018554 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.25336191 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.23056615 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.23056615 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.02966584 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.87335837 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.86343795 |
| 12 | activated T cell proliferation (GO:0050798) | 4.79432584 |
| 13 | positive T cell selection (GO:0043368) | 4.79224685 |
| 14 | urea metabolic process (GO:0019627) | 4.61091433 |
| 15 | urea cycle (GO:0000050) | 4.61091433 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.60799733 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.53486314 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.50599325 |
| 19 | positive thymic T cell selection (GO:0045059) | 4.50429275 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49604196 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 4.47740079 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 4.47740079 |
| 23 | tryptophan catabolic process (GO:0006569) | 4.47740079 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.38098682 |
| 25 | tolerance induction (GO:0002507) | 4.35587720 |
| 26 | kynurenine metabolic process (GO:0070189) | 4.32417309 |
| 27 | T cell selection (GO:0045058) | 4.32253840 |
| 28 | T cell migration (GO:0072678) | 4.23673422 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.21504000 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.20354497 |
| 31 | interferon-gamma production (GO:0032609) | 4.19462121 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17123086 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.16156710 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 4.15829178 |
| 35 | thymic T cell selection (GO:0045061) | 4.13340988 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.11700879 |
| 37 | response to interleukin-15 (GO:0070672) | 4.08112572 |
| 38 | bile acid metabolic process (GO:0008206) | 4.03161158 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.02786019 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 3.99776361 |
| 41 | complement activation, alternative pathway (GO:0006957) | 3.99735497 |
| 42 | regulation of fibrinolysis (GO:0051917) | 3.98879847 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.98728894 |
| 44 | protein carboxylation (GO:0018214) | 3.97331538 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.97331538 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.87502339 |
| 47 | cysteine metabolic process (GO:0006534) | 3.85251413 |
| 48 | phospholipid efflux (GO:0033700) | 3.77367734 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.76973154 |
| 50 | glyoxylate metabolic process (GO:0046487) | 3.76635773 |
| 51 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.73991561 |
| 52 | bile acid and bile salt transport (GO:0015721) | 3.70251946 |
| 53 | regulation of complement activation (GO:0030449) | 3.69863333 |
| 54 | intestinal cholesterol absorption (GO:0030299) | 3.69751049 |
| 55 | cellular extravasation (GO:0045123) | 3.68492937 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.67484468 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66902253 |
| 58 | glutamate metabolic process (GO:0006536) | 3.65599999 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.65576675 |
| 60 | triglyceride homeostasis (GO:0070328) | 3.65576675 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.65537600 |
| 62 | negative regulation of sterol transport (GO:0032372) | 3.64836514 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 3.64836514 |
| 64 | cholesterol efflux (GO:0033344) | 3.63742784 |
| 65 | regulation of cholesterol esterification (GO:0010872) | 3.63219623 |
| 66 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.62628874 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.59049599 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.59049599 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.59049599 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 3.57009483 |
| 71 | leukocyte aggregation (GO:0070486) | 3.54051191 |
| 72 | homocysteine metabolic process (GO:0050667) | 3.53976784 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.53496486 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 3.52678484 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49342852 |
| 76 | tyrosine metabolic process (GO:0006570) | 3.48146190 |
| 77 | drug catabolic process (GO:0042737) | 3.43661366 |
| 78 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40053788 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 3.39511488 |
| 80 | cellular response to ethanol (GO:0071361) | 3.39366537 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39179975 |
| 82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.37220045 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.35792966 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 3.34969582 |
| 85 | indolalkylamine metabolic process (GO:0006586) | 3.33322316 |
| 86 | coenzyme catabolic process (GO:0009109) | 3.31728585 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 3.24942942 |
| 88 | serine family amino acid catabolic process (GO:0009071) | 3.24813749 |
| 89 | cytolysis (GO:0019835) | 3.24337306 |
| 90 | negative regulation of interleukin-12 production (GO:0032695) | 3.24255159 |
| 91 | cellular glucuronidation (GO:0052695) | 3.22208640 |
| 92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.20449687 |
| 93 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.17759987 |
| 94 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.17402074 |
| 95 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.17402074 |
| 96 | modulation by symbiont of host immune response (GO:0052553) | 3.17402074 |
| 97 | positive regulation by symbiont of host defense response (GO:0052509) | 3.17402074 |
| 98 | modulation by symbiont of host defense response (GO:0052031) | 3.17402074 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.17402074 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 3.15208120 |
| 101 | lysine catabolic process (GO:0006554) | 3.14378799 |
| 102 | lysine metabolic process (GO:0006553) | 3.14378799 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.13115166 |
| 104 | plasma lipoprotein particle clearance (GO:0034381) | 3.13062501 |
| 105 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10634904 |
| 106 | ketone body metabolic process (GO:1902224) | 3.10410247 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.07278902 |
| 108 | macrophage activation involved in immune response (GO:0002281) | 3.07159891 |
| 109 | regulation of tolerance induction (GO:0002643) | 3.05618729 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.05346613 |
| 111 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03968207 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 3.01659263 |
| 113 | detection of other organism (GO:0098543) | 3.01636085 |
| 114 | T cell receptor signaling pathway (GO:0050852) | 3.00737007 |
| 115 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.00328303 |
| 116 | cellular amino acid catabolic process (GO:0009063) | 2.99482482 |
| 117 | alpha-beta T cell differentiation (GO:0046632) | 2.98505197 |
| 118 | cellular modified amino acid catabolic process (GO:0042219) | 2.97742131 |
| 119 | cholesterol homeostasis (GO:0042632) | 2.97642349 |
| 120 | amino-acid betaine metabolic process (GO:0006577) | 2.97397423 |
| 121 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97347603 |
| 122 | sterol homeostasis (GO:0055092) | 2.95979689 |
| 123 | protein-lipid complex assembly (GO:0065005) | 2.94613242 |
| 124 | positive regulation of tolerance induction (GO:0002645) | 2.94124088 |
| 125 | microglial cell activation (GO:0001774) | 2.93823376 |
| 126 | benzene-containing compound metabolic process (GO:0042537) | 2.90919069 |
| 127 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89227185 |
| 128 | intestinal absorption (GO:0050892) | 2.88626246 |
| 129 | flavonoid metabolic process (GO:0009812) | 2.88083352 |
| 130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87660375 |
| 131 | negative regulation of cell killing (GO:0031342) | 2.87660375 |
| 132 | mast cell activation (GO:0045576) | 2.86957251 |
| 133 | T-helper cell differentiation (GO:0042093) | 2.86750755 |
| 134 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.86750755 |
| 135 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86356713 |
| 136 | alpha-beta T cell activation (GO:0046631) | 2.86174070 |
| 137 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.85625607 |
| 138 | low-density lipoprotein particle remodeling (GO:0034374) | 2.85082991 |
| 139 | indole-containing compound metabolic process (GO:0042430) | 2.82851986 |
| 140 | amine catabolic process (GO:0009310) | 2.82820603 |
| 141 | cellular biogenic amine catabolic process (GO:0042402) | 2.82820603 |
| 142 | germinal center formation (GO:0002467) | 2.82661421 |
| 143 | glucuronate metabolic process (GO:0019585) | 2.82290382 |
| 144 | uronic acid metabolic process (GO:0006063) | 2.82290382 |
| 145 | negative regulation of protein activation cascade (GO:2000258) | 2.81647788 |
| 146 | regulation of B cell differentiation (GO:0045577) | 2.80130997 |
| 147 | imidazole-containing compound metabolic process (GO:0052803) | 2.80113616 |
| 148 | lipoprotein metabolic process (GO:0042157) | 2.79894589 |
| 149 | detection of bacterium (GO:0016045) | 2.79063652 |
| 150 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77672518 |
| 151 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77672518 |
| 152 | nucleobase catabolic process (GO:0046113) | 2.77054643 |
| 153 | fibrinolysis (GO:0042730) | 2.75944605 |
| 154 | plasma lipoprotein particle organization (GO:0071827) | 2.74835544 |
| 155 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.74382506 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.74347793 |
| 157 | positive regulation of B cell differentiation (GO:0045579) | 2.72029622 |
| 158 | myeloid cell activation involved in immune response (GO:0002275) | 2.71450982 |
| 159 | arginine metabolic process (GO:0006525) | 2.69843197 |
| 160 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.69313264 |
| 161 | opsonization (GO:0008228) | 2.67349532 |
| 162 | exogenous drug catabolic process (GO:0042738) | 2.67103112 |
| 163 | drug transmembrane transport (GO:0006855) | 2.64154638 |
| 164 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.63568136 |
| 165 | lipid homeostasis (GO:0055088) | 2.63507440 |
| 166 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.63357476 |
| 167 | short-chain fatty acid metabolic process (GO:0046459) | 2.63112847 |
| 168 | macrophage activation (GO:0042116) | 2.62958519 |
| 169 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.62660949 |
| 170 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61445697 |
| 171 | T cell proliferation (GO:0042098) | 2.60994080 |
| 172 | B cell homeostasis (GO:0001782) | 2.60845624 |
| 173 | T cell differentiation involved in immune response (GO:0002292) | 2.60300233 |
| 174 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.60300233 |
| 175 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.60300233 |
| 176 | cholesterol transport (GO:0030301) | 2.59707513 |
| 177 | sterol transport (GO:0015918) | 2.59707513 |
| 178 | positive regulation of Rap GTPase activity (GO:0032854) | 2.55344902 |
| 179 | positive regulation of interleukin-2 production (GO:0032743) | 2.54703069 |
| 180 | lymphocyte migration (GO:0072676) | 2.52328911 |
| 181 | dendritic cell migration (GO:0036336) | 2.51955643 |
| 182 | T cell homeostasis (GO:0043029) | 2.51750943 |
| 183 | hepatocyte apoptotic process (GO:0097284) | 2.51612024 |
| 184 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.51471584 |
| 185 | detection of external biotic stimulus (GO:0098581) | 2.51148040 |
| 186 | regulation of alpha-beta T cell activation (GO:0046634) | 2.50572148 |
| 187 | T cell costimulation (GO:0031295) | 2.49976398 |
| 188 | regulation of granulocyte differentiation (GO:0030852) | 2.49571887 |
| 189 | neutrophil activation involved in immune response (GO:0002283) | 2.49026101 |
| 190 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48288127 |
| 191 | lymphocyte costimulation (GO:0031294) | 2.45828768 |
| 192 | negative regulation of innate immune response (GO:0045824) | 2.44186728 |
| 193 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.43687392 |
| 194 | myeloid dendritic cell activation (GO:0001773) | 2.43520165 |
| 195 | negative regulation of adaptive immune response (GO:0002820) | 2.42041373 |
| 196 | respiratory burst (GO:0045730) | 2.41579533 |
| 197 | T cell differentiation (GO:0030217) | 2.41545343 |
| 198 | positive regulation of mast cell activation (GO:0033005) | 2.40887449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.93448670 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59188937 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31183313 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68688375 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.60122229 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.58024873 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.28103163 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.13629642 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.91464794 |
| 10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.76954996 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64625412 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64038994 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61987221 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.60011376 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.54418112 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.37799311 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.37152198 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.37145720 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13350376 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12767962 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09463449 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07264728 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07170937 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01325338 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97866546 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95104190 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.88450781 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86296630 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83927496 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.83912476 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82748453 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80482607 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78919752 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77386973 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70951611 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69719868 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64213591 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63700928 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62943216 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61531578 |
| 41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55317342 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.53716832 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52759120 |
| 44 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.50673063 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.50130078 |
| 46 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.49308940 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48289116 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45427193 |
| 49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43363759 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41720329 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41493339 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.41466316 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41260172 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41260172 |
| 55 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40814120 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40417955 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39171451 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35884314 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35582396 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34475543 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33146320 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33031064 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.32857568 |
| 64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31442814 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31275779 |
| 66 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.30300244 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29125379 |
| 68 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27662802 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27181885 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26876039 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25295367 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25294620 |
| 73 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.23001677 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22955504 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22811577 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22383117 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22162337 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20493303 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20416879 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20052150 |
| 81 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19143868 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18272773 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16400382 |
| 84 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15565757 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15537440 |
| 86 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15149019 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14847789 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14623754 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14441583 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13980636 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12104766 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11928455 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11161031 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11126981 |
| 95 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10965700 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10848386 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09243195 |
| 98 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09059290 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09040332 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08899930 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08692769 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08173996 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08148475 |
| 104 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07443524 |
| 105 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06659410 |
| 106 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06030539 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05649089 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05432829 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05363375 |
| 110 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05182300 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02934506 |
| 112 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02623292 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02415149 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02347390 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02098307 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01238730 |
| 117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00814599 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00335801 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00173743 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99968698 |
| 121 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.99700727 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99058119 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98993354 |
| 124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98922149 |
| 125 | * MAF_26560356_Chip-Seq_TH2_Human | 0.98439356 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97931631 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97322783 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97322783 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96935946 |
| 130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95322223 |
| 131 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94829482 |
| 132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94802681 |
| 133 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94714438 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93772226 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92635373 |
| 136 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92538506 |
| 137 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92280810 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91958944 |
| 139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91586563 |
| 140 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90211113 |
| 141 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89881612 |
| 142 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89300828 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88802991 |
| 144 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88630724 |
| 145 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88299356 |
| 146 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88240202 |
| 147 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87914544 |
| 148 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87874710 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.87599730 |
| 150 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87022504 |
| 151 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.86843023 |
| 152 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86123300 |
| 153 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85906134 |
| 154 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85173130 |
| 155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84954519 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83294701 |
| 157 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83161756 |
| 158 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82934706 |
| 159 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82835848 |
| 160 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82121710 |
| 161 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82076804 |
| 162 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82072129 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81323467 |
| 164 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81131140 |
| 165 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81004725 |
| 166 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80738369 |
| 167 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80473981 |
| 168 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80285010 |
| 169 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80029755 |
| 170 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79251150 |
| 171 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79227066 |
| 172 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78682646 |
| 173 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78643027 |
| 174 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.76965303 |
| 175 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75808964 |
| 176 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75472484 |
| 177 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75299968 |
| 178 | MYC_22102868_ChIP-Seq_BL_Human | 0.74736072 |
| 179 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74466021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.81241364 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.67874753 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.70338895 |
| 4 | MP0005365_abnormal_bile_salt | 5.28247611 |
| 5 | MP0002822_catalepsy | 4.20442970 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.84475858 |
| 7 | MP0003252_abnormal_bile_duct | 3.61260735 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.61192342 |
| 9 | MP0005671_abnormal_response_to | 3.45364257 |
| 10 | MP0000569_abnormal_digit_pigmentation | 3.40923232 |
| 11 | MP0003724_increased_susceptibility_to | 3.29755665 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.24121518 |
| 13 | MP0001835_abnormal_antigen_presentation | 3.16735079 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.89848524 |
| 15 | MP0001800_abnormal_humoral_immune | 2.70396294 |
| 16 | MP0003436_decreased_susceptibility_to | 2.61561766 |
| 17 | MP0000685_abnormal_immune_system | 2.58505409 |
| 18 | MP0005083_abnormal_biliary_tract | 2.54098401 |
| 19 | MP0001790_abnormal_immune_system | 2.51640258 |
| 20 | MP0005387_immune_system_phenotype | 2.51640258 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.40841952 |
| 22 | MP0003303_peritoneal_inflammation | 2.40725079 |
| 23 | MP0002723_abnormal_immune_serum | 2.29209141 |
| 24 | MP0006082_CNS_inflammation | 2.24851797 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.20393065 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.19605575 |
| 27 | MP0001819_abnormal_immune_cell | 2.16527986 |
| 28 | MP0002419_abnormal_innate_immunity | 2.15245077 |
| 29 | MP0005025_abnormal_response_to | 2.14933127 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 2.10506803 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 2.01734483 |
| 32 | MP0005332_abnormal_amino_acid | 2.00732084 |
| 33 | MP0002009_preneoplasia | 1.97696963 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.97364809 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.91647205 |
| 36 | MP0002405_respiratory_system_inflammati | 1.85482791 |
| 37 | MP0005310_abnormal_salivary_gland | 1.85304967 |
| 38 | MP0009785_altered_susceptibility_to | 1.84378886 |
| 39 | MP0003868_abnormal_feces_composition | 1.83488496 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.82568409 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.78466094 |
| 42 | MP0003195_calcinosis | 1.76192807 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.74401765 |
| 44 | MP0009840_abnormal_foam_cell | 1.70906309 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.69860005 |
| 46 | MP0000716_abnormal_immune_system | 1.68903653 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.68744515 |
| 48 | MP0000609_abnormal_liver_physiology | 1.66834341 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.65383665 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.64978534 |
| 51 | MP0002398_abnormal_bone_marrow | 1.64594664 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.58725148 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.57342638 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.52770084 |
| 55 | MP0001851_eye_inflammation | 1.51670604 |
| 56 | MP0009745_abnormal_behavioral_response | 1.51157721 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.50045195 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.47476097 |
| 59 | MP0001873_stomach_inflammation | 1.47351994 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.46228550 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.44967525 |
| 62 | MP0004381_abnormal_hair_follicle | 1.41979320 |
| 63 | MP0003828_pulmonary_edema | 1.41137378 |
| 64 | MP0002063_abnormal_learning/memory/cond | 1.40433181 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.39132019 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.38139553 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.36347530 |
| 68 | MP0003880_abnormal_central_pattern | 1.35871519 |
| 69 | MP0002722_abnormal_immune_system | 1.33050356 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.32213485 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.31085298 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.30496593 |
| 73 | MP0004947_skin_inflammation | 1.29801867 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.29500399 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.25691336 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.24184238 |
| 77 | MP0002933_joint_inflammation | 1.23485261 |
| 78 | MP0003787_abnormal_imprinting | 1.22183153 |
| 79 | MP0005535_abnormal_body_temperature | 1.21868469 |
| 80 | MP0009697_abnormal_copulation | 1.21710405 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.21007111 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20994022 |
| 83 | MP0002429_abnormal_blood_cell | 1.20263911 |
| 84 | MP0000604_amyloidosis | 1.20072195 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.19495445 |
| 86 | MP0004270_analgesia | 1.18599210 |
| 87 | MP0002396_abnormal_hematopoietic_system | 1.15224926 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.14755434 |
| 89 | MP0004510_myositis | 1.13599581 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 1.12014969 |
| 91 | MP0003329_amyloid_beta_deposits | 1.11322616 |
| 92 | MP0005448_abnormal_energy_balance | 1.09730357 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 1.08154880 |
| 94 | MP0008961_abnormal_basal_metabolism | 1.05074458 |
| 95 | MP0001486_abnormal_startle_reflex | 1.04558741 |
| 96 | MP0002254_reproductive_system_inflammat | 1.03507789 |
| 97 | MP0002064_seizures | 1.02314415 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 1.01589537 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 1.00521877 |
| 100 | MP0001764_abnormal_homeostasis | 0.97747246 |
| 101 | MP0001853_heart_inflammation | 0.97692218 |
| 102 | MP0008057_abnormal_DNA_replication | 0.94500992 |
| 103 | MP0008469_abnormal_protein_level | 0.93110830 |
| 104 | MP0008872_abnormal_physiological_respon | 0.92754017 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.92367797 |
| 106 | MP0004924_abnormal_behavior | 0.91210178 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.91210178 |
| 108 | MP0008874_decreased_physiological_sensi | 0.90349939 |
| 109 | MP0002006_tumorigenesis | 0.89221893 |
| 110 | MP0005646_abnormal_pituitary_gland | 0.87922813 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.87522298 |
| 112 | MP0004883_abnormal_blood_vessel | 0.86522090 |
| 113 | MP0003705_abnormal_hypodermis_morpholog | 0.84327322 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.84143026 |
| 115 | MP0004484_altered_response_of | 0.83784310 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.83518109 |
| 117 | MP0001986_abnormal_taste_sensitivity | 0.83424411 |
| 118 | MP0001177_atelectasis | 0.82296419 |
| 119 | MP0002163_abnormal_gland_morphology | 0.80551341 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.79170677 |
| 121 | MP0001968_abnormal_touch/_nociception | 0.78389029 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.78216273 |
| 123 | MP0002272_abnormal_nervous_system | 0.76981851 |
| 124 | MP0000371_diluted_coat_color | 0.76969901 |
| 125 | MP0008569_lethality_at_weaning | 0.76199309 |
| 126 | MP0003879_abnormal_hair_cell | 0.76130001 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.75902482 |
| 128 | MP0002971_abnormal_brown_adipose | 0.73517917 |
| 129 | MP0004043_abnormal_pH_regulation | 0.73495145 |
| 130 | MP0008260_abnormal_autophagy | 0.73273845 |
| 131 | MP0006276_abnormal_autonomic_nervous | 0.73093617 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.72983921 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.71917096 |
| 134 | MP0000920_abnormal_myelination | 0.71890807 |
| 135 | MP0004130_abnormal_muscle_cell | 0.71878968 |
| 136 | MP0000249_abnormal_blood_vessel | 0.70447026 |
| 137 | MP0001663_abnormal_digestive_system | 0.70313649 |
| 138 | MP0005334_abnormal_fat_pad | 0.69813705 |
| 139 | MP0005636_abnormal_mineral_homeostasis | 0.68859142 |
| 140 | MP0008877_abnormal_DNA_methylation | 0.67585084 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.67579431 |
| 142 | MP0009046_muscle_twitch | 0.67308851 |
| 143 | MP0003633_abnormal_nervous_system | 0.67191624 |
| 144 | MP0002557_abnormal_social/conspecific_i | 0.66811638 |
| 145 | MP0002069_abnormal_eating/drinking_beha | 0.66650937 |
| 146 | MP0009278_abnormal_bone_marrow | 0.66618940 |
| 147 | MP0010368_abnormal_lymphatic_system | 0.66295822 |
| 148 | MP0004808_abnormal_hematopoietic_stem | 0.65870532 |
| 149 | MP0001944_abnormal_pancreas_morphology | 0.64379131 |
| 150 | MP0009764_decreased_sensitivity_to | 0.63891479 |
| 151 | MP0004142_abnormal_muscle_tone | 0.63536697 |
| 152 | MP0002693_abnormal_pancreas_physiology | 0.62685371 |
| 153 | MP0000230_abnormal_systemic_arterial | 0.62280469 |
| 154 | MP0003959_abnormal_lean_body | 0.62256972 |
| 155 | MP0003953_abnormal_hormone_level | 0.62194087 |
| 156 | MP0001529_abnormal_vocalization | 0.62032613 |
| 157 | MP0005451_abnormal_body_composition | 0.60957309 |
| 158 | MP0003091_abnormal_cell_migration | 0.60595345 |
| 159 | MP0009115_abnormal_fat_cell | 0.59919758 |
| 160 | MP0000598_abnormal_liver_morphology | 0.59882762 |
| 161 | MP0003656_abnormal_erythrocyte_physiolo | 0.58939997 |
| 162 | MP0005647_abnormal_sex_gland | 0.58546297 |
| 163 | MP0005166_decreased_susceptibility_to | 0.58006755 |
| 164 | MP0009384_cardiac_valve_regurgitation | 0.57757716 |
| 165 | MP0002928_abnormal_bile_duct | 0.57704846 |
| 166 | MP0009763_increased_sensitivity_to | 0.57067312 |
| 167 | MP0003690_abnormal_glial_cell | 0.56565435 |
| 168 | MP0003866_abnormal_defecation | 0.55879314 |
| 169 | MP0001756_abnormal_urination | 0.55738017 |
| 170 | MP0001545_abnormal_hematopoietic_system | 0.55639460 |
| 171 | MP0005397_hematopoietic_system_phenotyp | 0.55639460 |
| 172 | MP0001502_abnormal_circadian_rhythm | 0.55629386 |
| 173 | MP0003632_abnormal_nervous_system | 0.55558033 |
| 174 | MP0001765_abnormal_ion_homeostasis | 0.55257280 |
| 175 | MP0003045_fibrosis | 0.54742783 |
| 176 | MP0001984_abnormal_olfaction | 0.53705381 |
| 177 | MP0000639_abnormal_adrenal_gland | 0.52838998 |
| 178 | MP0005187_abnormal_penis_morphology | 0.52615136 |
| 179 | MP0002734_abnormal_mechanical_nocicepti | 0.51337940 |
| 180 | MP0002733_abnormal_thermal_nociception | 0.50780559 |
| 181 | MP0001661_extended_life_span | 0.49473300 |
| 182 | MP0006035_abnormal_mitochondrial_morpho | 0.49060953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.12397971 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.06782287 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.93244809 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.76038645 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.45012067 |
| 6 | Xanthomatosis (HP:0000991) | 5.34499742 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.33509980 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.14134275 |
| 9 | T lymphocytopenia (HP:0005403) | 5.01712016 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 4.76850543 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.75156425 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.52883149 |
| 13 | Complement deficiency (HP:0004431) | 4.40326545 |
| 14 | Stomatitis (HP:0010280) | 4.28879829 |
| 15 | Epidermoid cyst (HP:0200040) | 4.27953532 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.18235546 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15060069 |
| 18 | Recurrent abscess formation (HP:0002722) | 4.08449557 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.04087555 |
| 20 | Fat malabsorption (HP:0002630) | 3.92645967 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.76519333 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.62230694 |
| 23 | Ketosis (HP:0001946) | 3.60615091 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.60084907 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.54373227 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.54373227 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.54373227 |
| 28 | Acanthocytosis (HP:0001927) | 3.52283284 |
| 29 | Myositis (HP:0100614) | 3.51631147 |
| 30 | Joint hemorrhage (HP:0005261) | 3.46369001 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.41762269 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41155265 |
| 33 | Optic neuritis (HP:0100653) | 3.37202494 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.37202494 |
| 35 | Spontaneous hematomas (HP:0007420) | 3.35114389 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31291602 |
| 37 | Abnormality of T cells (HP:0002843) | 3.30924499 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.25435480 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21780794 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21780794 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20731355 |
| 42 | Pustule (HP:0200039) | 3.17764274 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 3.15995380 |
| 44 | Hypercholesterolemia (HP:0003124) | 3.14582194 |
| 45 | Orchitis (HP:0100796) | 3.13385287 |
| 46 | Hyperammonemia (HP:0001987) | 3.12504577 |
| 47 | Recurrent skin infections (HP:0001581) | 3.06613843 |
| 48 | Hyperglycinemia (HP:0002154) | 3.06477390 |
| 49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.05738375 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 3.05123912 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.03806801 |
| 52 | Abnormality of complement system (HP:0005339) | 2.91757004 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88616520 |
| 54 | Ketoacidosis (HP:0001993) | 2.87533918 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.86912244 |
| 56 | Skin nodule (HP:0200036) | 2.84935123 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.84222516 |
| 58 | Chronic diarrhea (HP:0002028) | 2.78291896 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.75414390 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.74037118 |
| 61 | Abnormality of methionine metabolism (HP:0010901) | 2.73799009 |
| 62 | Meningitis (HP:0001287) | 2.73699365 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.73522865 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.72703100 |
| 65 | Vasculitis (HP:0002633) | 2.68228063 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.66826814 |
| 67 | Myokymia (HP:0002411) | 2.65476327 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.65228395 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.64798332 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64798332 |
| 71 | Spontaneous abortion (HP:0005268) | 2.64571962 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.62723547 |
| 73 | Hyperglycinuria (HP:0003108) | 2.62663723 |
| 74 | Papilledema (HP:0001085) | 2.61924179 |
| 75 | Hemoptysis (HP:0002105) | 2.61905447 |
| 76 | Hematochezia (HP:0002573) | 2.59208008 |
| 77 | Encephalitis (HP:0002383) | 2.56860878 |
| 78 | Hyperventilation (HP:0002883) | 2.56414330 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.53743156 |
| 80 | Recurrent viral infections (HP:0004429) | 2.53721183 |
| 81 | Focal motor seizures (HP:0011153) | 2.48597325 |
| 82 | Gingivitis (HP:0000230) | 2.47662122 |
| 83 | Leukocytosis (HP:0001974) | 2.45817263 |
| 84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45786122 |
| 85 | Global brain atrophy (HP:0002283) | 2.44339120 |
| 86 | Panhypogammaglobulinemia (HP:0003139) | 2.43303310 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.43133968 |
| 88 | Chest pain (HP:0100749) | 2.42827532 |
| 89 | Sensorimotor neuropathy (HP:0007141) | 2.41010920 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.39137770 |
| 91 | Hemiplegia (HP:0002301) | 2.38880787 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.38167994 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 2.37539260 |
| 94 | Myocardial infarction (HP:0001658) | 2.34820538 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 2.34796509 |
| 96 | Steatorrhea (HP:0002570) | 2.34411305 |
| 97 | Recurrent bronchitis (HP:0002837) | 2.33921209 |
| 98 | Fair hair (HP:0002286) | 2.32844663 |
| 99 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30488827 |
| 100 | Gout (HP:0001997) | 2.30343971 |
| 101 | Obstructive lung disease (HP:0006536) | 2.28871226 |
| 102 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28871226 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24704051 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.22054861 |
| 105 | IgM deficiency (HP:0002850) | 2.21612392 |
| 106 | Abnormality of purine metabolism (HP:0004352) | 2.21432381 |
| 107 | Eosinophilia (HP:0001880) | 2.21401729 |
| 108 | Decreased circulating renin level (HP:0003351) | 2.20419822 |
| 109 | Torticollis (HP:0000473) | 2.19610312 |
| 110 | IgG deficiency (HP:0004315) | 2.18352828 |
| 111 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17069818 |
| 112 | Scanning speech (HP:0002168) | 2.16689223 |
| 113 | Status epilepticus (HP:0002133) | 2.16125634 |
| 114 | Symptomatic seizures (HP:0011145) | 2.15942089 |
| 115 | Ocular albinism (HP:0001107) | 2.15768108 |
| 116 | Limb hypertonia (HP:0002509) | 2.14253088 |
| 117 | Mitral stenosis (HP:0001718) | 2.14183186 |
| 118 | Metabolic acidosis (HP:0001942) | 2.13233808 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11586556 |
| 120 | Mucopolysacchariduria (HP:0008155) | 2.11586556 |
| 121 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11379305 |
| 122 | Inflammation of the large intestine (HP:0002037) | 2.10440570 |
| 123 | Vacuolated lymphocytes (HP:0001922) | 2.10299352 |
| 124 | Increased CSF protein (HP:0002922) | 2.10010544 |
| 125 | Focal seizures (HP:0007359) | 2.09068393 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07459839 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07459839 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07459839 |
| 129 | Disinhibition (HP:0000734) | 2.07095934 |
| 130 | Dysmetric saccades (HP:0000641) | 2.06578919 |
| 131 | Neonatal onset (HP:0003623) | 2.06314553 |
| 132 | Subacute progressive viral hepatitis (HP:0006572) | 2.06029895 |
| 133 | Abnormal gallbladder morphology (HP:0012437) | 2.05006175 |
| 134 | Prolonged bleeding time (HP:0003010) | 2.04636359 |
| 135 | Combined immunodeficiency (HP:0005387) | 2.04423842 |
| 136 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.04189174 |
| 137 | Arterial thrombosis (HP:0004420) | 2.04173030 |
| 138 | Granulocytopenia (HP:0001913) | 2.03417589 |
| 139 | Thyroiditis (HP:0100646) | 2.03287584 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 2.02768264 |
| 141 | Cholecystitis (HP:0001082) | 2.02768264 |
| 142 | Gingival bleeding (HP:0000225) | 2.02320379 |
| 143 | Hyperglycemia (HP:0003074) | 2.01064534 |
| 144 | Abnormal social behavior (HP:0012433) | 2.00552003 |
| 145 | Impaired social interactions (HP:0000735) | 2.00552003 |
| 146 | Craniofacial dystonia (HP:0012179) | 2.00527484 |
| 147 | Abnormality of the fingertips (HP:0001211) | 2.00493252 |
| 148 | Poikilocytosis (HP:0004447) | 2.00447423 |
| 149 | Loss of speech (HP:0002371) | 2.00061683 |
| 150 | Slow saccadic eye movements (HP:0000514) | 1.99892553 |
| 151 | Irritability (HP:0000737) | 1.97400251 |
| 152 | Pancreatitis (HP:0001733) | 1.97307313 |
| 153 | Vascular calcification (HP:0004934) | 1.96828668 |
| 154 | Hypophosphatemic rickets (HP:0004912) | 1.94897670 |
| 155 | Cerebral inclusion bodies (HP:0100314) | 1.93155187 |
| 156 | Epistaxis (HP:0000421) | 1.92562824 |
| 157 | Focal dystonia (HP:0004373) | 1.91443148 |
| 158 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.91273152 |
| 159 | Acute hepatic failure (HP:0006554) | 1.90955707 |
| 160 | Joint swelling (HP:0001386) | 1.90473289 |
| 161 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90384473 |
| 162 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90355647 |
| 163 | Urticaria (HP:0001025) | 1.89925126 |
| 164 | Malnutrition (HP:0004395) | 1.89131314 |
| 165 | Amyloidosis (HP:0011034) | 1.88823248 |
| 166 | Abnormality of the prostate (HP:0008775) | 1.88537044 |
| 167 | Esophageal varix (HP:0002040) | 1.88522971 |
| 168 | Stomach cancer (HP:0012126) | 1.88435931 |
| 169 | Cholelithiasis (HP:0001081) | 1.88231739 |
| 170 | Gastrointestinal inflammation (HP:0004386) | 1.88042328 |
| 171 | Generalized hypopigmentation of hair (HP:0011358) | 1.85626621 |
| 172 | Pulmonary embolism (HP:0002204) | 1.83616334 |
| 173 | Anxiety (HP:0000739) | 1.83202250 |
| 174 | Colitis (HP:0002583) | 1.82687062 |
| 175 | Rickets (HP:0002748) | 1.82184026 |
| 176 | Late onset (HP:0003584) | 1.81252706 |
| 177 | Neurofibrillary tangles (HP:0002185) | 1.81206289 |
| 178 | Menorrhagia (HP:0000132) | 1.80984497 |
| 179 | Polyneuropathy (HP:0001271) | 1.79646968 |
| 180 | Iris hypopigmentation (HP:0007730) | 1.79491196 |
| 181 | Abnormality of the pleura (HP:0002103) | 1.78262569 |
| 182 | Cardiovascular calcification (HP:0011915) | 1.78194537 |
| 183 | Thrombophlebitis (HP:0004418) | 1.77975932 |
| 184 | Increased IgM level (HP:0003496) | 1.75561819 |
| 185 | Alveolar cell carcinoma (HP:0006519) | 1.75345734 |
| 186 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74972112 |
| 187 | Enlarged kidneys (HP:0000105) | 1.74195586 |
| 188 | Dysdiadochokinesis (HP:0002075) | 1.73627213 |
| 189 | Albinism (HP:0001022) | 1.73478897 |
| 190 | Papilloma (HP:0012740) | 1.72935386 |
| 191 | Verrucae (HP:0200043) | 1.72935386 |
| 192 | Blue irides (HP:0000635) | 1.71098152 |
| 193 | Lymphopenia (HP:0001888) | 1.70999731 |
| 194 | Abnormality of proline metabolism (HP:0010907) | 1.70771684 |
| 195 | Hydroxyprolinuria (HP:0003080) | 1.70771684 |
| 196 | Glomerulonephritis (HP:0000099) | 1.69248643 |
| 197 | Death in childhood (HP:0003819) | 1.68884020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.85250718 |
| 2 | NTRK3 | 3.19638111 |
| 3 | FRK | 2.88359207 |
| 4 | FGFR4 | 2.67319301 |
| 5 | INSRR | 2.39636698 |
| 6 | PRPF4B | 2.34611384 |
| 7 | BLK | 2.28962220 |
| 8 | DAPK2 | 2.23262048 |
| 9 | SIK1 | 1.97869716 |
| 10 | MAP3K2 | 1.85174078 |
| 11 | ZAP70 | 1.84053658 |
| 12 | MAP3K9 | 1.82168502 |
| 13 | MAP2K4 | 1.81521333 |
| 14 | FGFR2 | 1.79051503 |
| 15 | IRAK4 | 1.66194281 |
| 16 | MAP3K4 | 1.63967611 |
| 17 | SIK2 | 1.59070994 |
| 18 | BTK | 1.53917746 |
| 19 | MARK1 | 1.48941245 |
| 20 | SYK | 1.48590062 |
| 21 | NTRK1 | 1.47481342 |
| 22 | ACVR1B | 1.46559962 |
| 23 | NTRK2 | 1.45854673 |
| 24 | HCK | 1.44648301 |
| 25 | GRK6 | 1.43384507 |
| 26 | KSR1 | 1.42013722 |
| 27 | RIPK1 | 1.41353479 |
| 28 | LCK | 1.41097274 |
| 29 | MAP3K13 | 1.39938211 |
| 30 | MINK1 | 1.39251731 |
| 31 | KSR2 | 1.39204257 |
| 32 | PIK3CG | 1.36708402 |
| 33 | TEC | 1.34057281 |
| 34 | FGFR3 | 1.32366541 |
| 35 | BCKDK | 1.32106925 |
| 36 | JAK1 | 1.28106975 |
| 37 | ITK | 1.23502334 |
| 38 | TAOK3 | 1.23317121 |
| 39 | CAMKK1 | 1.22441221 |
| 40 | PRKCH | 1.21070208 |
| 41 | MAP3K7 | 1.19132440 |
| 42 | SGK2 | 1.18626058 |
| 43 | MAP3K12 | 1.17309425 |
| 44 | RIPK4 | 1.13737284 |
| 45 | GRK7 | 1.12018076 |
| 46 | LYN | 1.10626328 |
| 47 | PRKCQ | 1.09020740 |
| 48 | PAK3 | 1.08374199 |
| 49 | SGK3 | 1.06235919 |
| 50 | MAP3K10 | 1.04724827 |
| 51 | MST1R | 1.04092355 |
| 52 | TAOK1 | 1.00505686 |
| 53 | PASK | 1.00159958 |
| 54 | MAPK12 | 0.99869210 |
| 55 | TXK | 0.98575549 |
| 56 | STK11 | 0.98494186 |
| 57 | CDK5 | 0.95940528 |
| 58 | IRAK1 | 0.95715661 |
| 59 | TGFBR2 | 0.94982479 |
| 60 | RET | 0.94743941 |
| 61 | MAP3K1 | 0.93884762 |
| 62 | FES | 0.92011810 |
| 63 | IKBKB | 0.91386040 |
| 64 | ERBB4 | 0.91111441 |
| 65 | CAMK4 | 0.90783471 |
| 66 | TNIK | 0.90666209 |
| 67 | CSF1R | 0.88812739 |
| 68 | EPHA3 | 0.88539940 |
| 69 | SGK223 | 0.88113018 |
| 70 | SGK494 | 0.88113018 |
| 71 | MAP2K7 | 0.87243601 |
| 72 | CASK | 0.86638168 |
| 73 | TNK2 | 0.85386858 |
| 74 | CAMKK2 | 0.84229195 |
| 75 | MARK3 | 0.82915331 |
| 76 | MAPK7 | 0.81437560 |
| 77 | DAPK1 | 0.80448720 |
| 78 | NUAK1 | 0.79212645 |
| 79 | BMPR2 | 0.78267969 |
| 80 | JAK2 | 0.77949081 |
| 81 | TRPM7 | 0.72794566 |
| 82 | YES1 | 0.72696009 |
| 83 | IKBKE | 0.72497802 |
| 84 | EPHB1 | 0.72493681 |
| 85 | JAK3 | 0.72299518 |
| 86 | STK38 | 0.72160668 |
| 87 | MAPK11 | 0.71863079 |
| 88 | PRKCZ | 0.71628667 |
| 89 | MARK2 | 0.70883285 |
| 90 | CAMK2A | 0.70752875 |
| 91 | MAP2K3 | 0.69837371 |
| 92 | TBK1 | 0.69667195 |
| 93 | PDGFRA | 0.69478424 |
| 94 | RAF1 | 0.68549222 |
| 95 | PRKCG | 0.68243858 |
| 96 | CAMK2B | 0.67943776 |
| 97 | CSK | 0.66511594 |
| 98 | PIM1 | 0.65908199 |
| 99 | PDK1 | 0.64664157 |
| 100 | LATS1 | 0.64598322 |
| 101 | FGR | 0.64560948 |
| 102 | BRD4 | 0.64477954 |
| 103 | TYRO3 | 0.63927705 |
| 104 | SGK1 | 0.63080956 |
| 105 | NLK | 0.61590358 |
| 106 | TYK2 | 0.60948132 |
| 107 | MAP2K1 | 0.59720159 |
| 108 | WNK1 | 0.58120502 |
| 109 | SIK3 | 0.57653929 |
| 110 | CAMK1D | 0.56021905 |
| 111 | ADRBK2 | 0.54845931 |
| 112 | PTK6 | 0.54755739 |
| 113 | CAMK1G | 0.54567423 |
| 114 | CDK6 | 0.54363432 |
| 115 | MAP4K1 | 0.54070052 |
| 116 | PRKACG | 0.53807450 |
| 117 | PDPK1 | 0.53273154 |
| 118 | PRKD3 | 0.53217183 |
| 119 | FER | 0.53198736 |
| 120 | KIT | 0.52948157 |
| 121 | FYN | 0.52766572 |
| 122 | ERBB2 | 0.52241145 |
| 123 | MAPK15 | 0.52086535 |
| 124 | PKN2 | 0.51831636 |
| 125 | CAMK1 | 0.51760203 |
| 126 | PAK6 | 0.51449929 |
| 127 | CDC42BPA | 0.51193614 |
| 128 | MAP3K6 | 0.50687268 |
| 129 | HIPK2 | 0.50401171 |
| 130 | PRKAA2 | 0.49833714 |
| 131 | MELK | 0.49436296 |
| 132 | LMTK2 | 0.49273494 |
| 133 | PRKCB | 0.49219362 |
| 134 | PDGFRB | 0.48699612 |
| 135 | RPS6KA3 | 0.47790264 |
| 136 | CHUK | 0.47664487 |
| 137 | ERN1 | 0.47279494 |
| 138 | DYRK1B | 0.46416355 |
| 139 | CSNK1G2 | 0.46413143 |
| 140 | UHMK1 | 0.46070029 |
| 141 | FGFR1 | 0.45855116 |
| 142 | MAP3K14 | 0.45724854 |
| 143 | PTK2 | 0.40707335 |
| 144 | IGF1R | 0.40374797 |
| 145 | MAP2K6 | 0.39950455 |
| 146 | PIK3CA | 0.39204425 |
| 147 | RPS6KA6 | 0.38132338 |
| 148 | IRAK2 | 0.37874936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.09860155 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.91721064 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82125711 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81088777 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73165535 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.44830193 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.30755751 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23586680 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19415241 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18262646 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.12838487 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12029526 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10395156 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.05534652 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.99824773 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96975201 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96097742 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92471661 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92226916 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90695627 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84178695 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.81374071 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78395441 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78329404 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69773218 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.69155870 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67195302 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66227649 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58573990 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53105722 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51937642 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.50879606 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48967167 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.48785074 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48636370 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.46642461 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45609063 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45558183 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44559073 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37580563 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36468244 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.35673286 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35347933 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34818361 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34674672 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33538981 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31791152 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30958567 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29781773 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29742400 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28584045 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27065778 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25596232 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25457609 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25387582 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24551287 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24477407 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22256353 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22181861 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20926513 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20213342 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20188301 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20126797 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19628939 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17598524 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17518796 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 1.16684743 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15514395 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15323175 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14881026 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13959345 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10169717 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 1.09946927 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07597567 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05290774 |
| 76 | Asthma_Homo sapiens_hsa05310 | 1.04510924 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03531295 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00218907 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00205164 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99506873 |
| 81 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98234267 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96641184 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95728448 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94909538 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94294533 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93435477 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.91711088 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.90426319 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89866262 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88101862 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86659753 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86179950 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85449907 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84994651 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.84621563 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.83728542 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83549527 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82804550 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82622600 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82138335 |
| 101 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82020065 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.81651340 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80710742 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.80285247 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79583412 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.77996060 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77099202 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75613516 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74342365 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73589366 |
| 111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73509227 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.69935774 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.69623943 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.69222732 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.69190424 |
| 116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68140808 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67971559 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67795150 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.67138144 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66705375 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66679660 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66316704 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66017327 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65921740 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64965808 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64884026 |
| 127 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63804854 |
| 128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63275566 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63236781 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.62953025 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62850138 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.62469488 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60562960 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60531536 |
| 135 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60226854 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59999998 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59843980 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59740529 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58044967 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56657382 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56415078 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55552261 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54256631 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53547823 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52936509 |
| 146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52756703 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51970936 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49024194 |
| 149 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48936336 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48724315 |
| 151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47749784 |
| 152 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47326135 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.44883238 |
| 154 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44222323 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41488738 |
| 156 | Taste transduction_Homo sapiens_hsa04742 | 0.41154394 |
| 157 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40742556 |
| 158 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40613864 |
| 159 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40368509 |
| 160 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39660292 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37911836 |
| 162 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37376538 |
| 163 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36703794 |
| 164 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33663237 |
| 165 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33458437 |
| 166 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31680402 |
| 167 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31189766 |
| 168 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30718313 |
| 169 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30269505 |
| 170 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29887066 |
| 171 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28292625 |
| 172 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.26718047 |
| 173 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26657099 |
| 174 | Long-term depression_Homo sapiens_hsa04730 | 0.26471859 |
| 175 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25014421 |
| 176 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23866825 |
| 177 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23486750 |
| 178 | Gap junction_Homo sapiens_hsa04540 | 0.22567261 |
| 179 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20333352 |

